HIMS

Hims & Hers Health Inc

Oct 15 • 01:15PM ET

56.97

+2.95 5.47 %

Healthcare • Drug Manufacturers - Specialty & Generic • USA • NYSE

Peers: ELF LFMD PRGO TDOC GDRX AMWL DOCS CLOV RXRX TWST

| Held by: IJH IWM VTI VB ULTY VBK IWO VXF XMHQ MDY

Index	RUT	P/E	71.31	EPS (ttm)	0.80	Insider Own	10.33%	Shs Outstand	217.38M	Perf Week	-2.05%
Market Cap	12.88B	Forward P/E	72.23	EPS next Y	0.79	Insider Trans	-9.72%	Shs Float	202.68M	Perf Month	11.96%
Enterprise Value	12.78B	PEG	2.80	EPS next Q	0.10	Inst Own	77.82%	Short Float	35.04%	Perf Quarter	13.97%
Income	193.60M	P/S	6.40	EPS this Y	7.56%	Inst Trans	9.76%	Short Ratio	2.38	Perf Half Y	93.40%
Sales	2.01B	P/B	22.86	EPS next Y	38.37%	ROA	16.42%	Short Interest	71.01M	Perf YTD	135.63%
Book/sh	2.49	P/C	11.25	EPS next 5Y	25.47%	ROE	41.88%	52W High	72.98 -21.93%	Perf Year	204.84%
Cash/sh	5.06	P/FCF	110.56	EPS past 3/5Y	- 17.22%	ROIC	12.07%	52W Low	18.33 210.91%	Perf 3Y	1041.78%
Dividend Est.	-	EV/EBITDA	76.95	Sales past 3/5Y	75.77% -	Gross Margin	67.11%	Volatility	6.97% 6.78%	Perf 5Y	450.48%
Dividend TTM	-	EV/Sales	6.35	EPS Y/Y TTM	947.74%	Oper. Margin	6.80%	ATR (14)	3.65	Perf 10Y	-
Dividend Ex-Date	-	Quick Ratio	4.46	Sales Y/Y TTM	88.69%	Profit Margin	9.62%	RSI (14)	54.71	Recom	2.82
Dividend Gr. 3/5Y	- -	Current Ratio	4.98	EPS Q/Q	198.06%	SMA20	1.23%	Beta	2.23	Target Price	50.66
Payout	0.00%	Debt/Eq	1.86	Sales Q/Q	72.61%	SMA50	11.83%	Rel Volume	1.17	Prev Close	54.02
Employees	1637	LT Debt/Eq	1.85	Earnings	Aug 04 AMC	SMA200	26.59%	Avg Volume	29.90M	Price	56.97
IPO	Sep 13, 2019	Option/Short	Yes / Yes	EPS/Sales Surpr.	12.73% -1.24%	Trades		Volume	20,876,704	Change	5.47%

Date	Action	Analyst	Rating Change	Price Target Change
Jun-23-25	Downgrade	Needham	Buy → Hold
Jun-04-25	Reiterated	Needham	Buy	$61 → $65
Apr-29-25	Downgrade	TD Cowen	Buy → Hold	$30
Feb-18-25	Downgrade	Morgan Stanley	Overweight → Equal-Weight	$42 → $60
Jan-10-25	Downgrade	Citigroup	Neutral → Sell	$24 → $25
Jan-07-25	Initiated	BTIG Research	Buy	$35
Dec-17-24	Initiated	Morgan Stanley	Overweight	$42
Nov-14-24	Downgrade	BofA Securities	Buy → Underperform
Aug-22-24	Initiated	Needham	Buy	$24
Aug-09-24	Downgrade	Imperial Capital	Outperform → In-line
May-22-24	Downgrade	Citigroup	Buy → Neutral	$16 → $20
Apr-16-24	Downgrade	Jefferies	Buy → Hold	$17 → $15
Apr-10-24	Initiated	Canaccord Genuity	Buy	$20
Feb-28-24	Upgrade	Imperial Capital	In-line → Outperform	$16
Feb-26-24	Initiated	Leerink Partners	Market Perform	$10
Dec-07-23	Initiated	Imperial Capital	In-line	$9
Jul-28-23	Initiated	TD Cowen	Outperform	$11
Apr-11-23	Initiated	Robert W. Baird	Neutral	$10
Feb-09-23	Upgrade	Jefferies	Hold → Buy	$7 → $11
Nov-08-22	Upgrade	SVB Leerink	Mkt Perform → Outperform	$5

Show Previous Ratings

Today 11:35AM	IBD 50's Hims & Hers Surges After Announcing A Menopause Care Launch (Investor's Business Daily) +5.47%
08:55AM	Hims & Hers to Offer Treatments for Menopause, Perimenopause (The Wall Street Journal)
09:00AM	Hers Launches Menopause and Perimenopause Specialty, Taking the Next Step Toward $1B of Hers Revenue in 2026 (Business Wire)
Oct-14-25 02:58PM	Dow Jones Tech Titan Apple Eyes Latest Buy Point Amid Stock Market Volatility (Investor's Business Daily)
01:13PM	Hims & Hers Gains 3.8% in 3 Months: Time to Hold the Stock or Sell? (Zacks)
04:05PM	Loading…
Oct-13-25 04:05PM	Hims & Hers to Announce Third Quarter 2025 Financial Results on November 3, 2025 (Business Wire)
Oct-10-25 05:45PM	Hims & Hers Health, Inc. (HIMS) Dips More Than Broader Market: What You Should Know (Zacks) -7.38%
02:50PM	Why Hims & Hers Health (HIMS) Stock Is Nosediving (StockStory)
02:04PM	Taking Advantage Of Hims & Hers Stock Volatility (Investor's Business Daily)
Oct-09-25 03:00PM	How Hims & Hers founder Joe Spector turned 10 failures into $1B idea (Yahoo Finance Video)
03:00PM	One founder's 3 rules for breaking into a complex market (Yahoo Finance Video)
01:53PM	Hims & Hers Expands Personalized Care Access Via Telehealth Platform (Zacks)
09:00AM	Customers Say Care Through Hims & Hers Matches, or Beats, the Doctors Office (Business Wire)
Oct-08-25 04:47PM	Hims Stock, Up 138%: IBD Stock Of The Day Makes Another Breakout Run (Investor's Business Daily)
01:25PM	Hims & Hers (HIMS) Jumps on Leadership Changes, Global Initiatives (Insider Monkey)
05:33AM	Loading…
05:33AM	Jim Cramer Says Hims & Hers is a "Very Hard Stock to Own" (Insider Monkey)
Oct-07-25 12:58PM	Hims Stock Catapults 126% As Obesity-Drug Wars Wage On Amid FDA Scrutiny (Investor's Business Daily) +5.86%
12:56PM	Hims Stock Catapults 126% As Obesity-Drug Wars Rage On Amid FDA Scrutiny (Investor's Business Daily)
09:00AM	Hims & Hers Health, Inc. (HIMS) is Attracting Investor Attention: Here is What You Should Know (Zacks)
Oct-03-25 06:27PM	Why Hims & Hers Stock Slipped Today (Motley Fool) -9.21%
09:58AM	Hims & Hers Expands Health Access Through Subscription Revenue Model (Zacks)
Oct-02-25 04:12PM	Breakout Stocks Watch: What Looms For October? (Investor's Business Daily)
04:07PM	A health-care stock that's maintaining momentum despite regulatory headwinds (CNBC TV)
Oct-01-25 11:40AM	OMCL or HIMS: Which Is the Better Value Stock Right Now? (Zacks)
08:00AM	Oktoberfest For Stocks Begins. Will It Be A Happy Or Spooky Halloween? (Investor's Business Daily)
03:15AM	The Secret to Finding the Next Amazon Is Hiding in Plain Sight (Motley Fool)
Sep-29-25 05:45PM	Hims & Hers Health, Inc. (HIMS) Laps the Stock Market: Here's Why (Zacks)
Sep-27-25 11:13AM	3 Healthcare Stocks Using AI to Drive Growth (MarketBeat)
Sep-26-25 11:04AM	HIMS vs. DOCS: Which Digital Health Platform Is a Better Investment? (Zacks) +6.43%
09:00AM	Hims & Hers Health, Inc. (HIMS) Is a Trending Stock: Facts to Know Before Betting on It (Zacks)
08:05AM	Loading…
08:05AM	A Healthcare Debate: Progyny vs. Hims & Hers (Motley Fool)
12:35AM	1 Momentum Stock with Competitive Advantages and 2 We Find Risky (StockStory)
Sep-23-25 05:45PM	Hims & Hers Health, Inc. (HIMS) Sees a More Significant Dip Than Broader Market: Some Facts to Know (Zacks)
02:12PM	HIMS Stock Just Got Rocked (Again) By the FDA. This Analyst Still Thinks Hims & Hers Can Surge 50%. (Barchart)
12:56PM	Why Hims & Hers Health (HIMS) Shares Are Trading Lower Today (StockStory)
Sep-22-25 12:45PM	Hims & Hers Expands Care Ecosystem via Global and Digital Innovation (Zacks)
09:00AM	3 Big Short Interest Names with Bullish Setups (MarketBeat)
Sep-21-25 10:08AM	Hims & Hers Stock Pushes to Highs on Healthcare Rate Cut Frenzy (MarketBeat)
Sep-19-25 12:11PM	Hims & Hers Health (HIMS) Stock Trades Up, Here Is Why (StockStory)
10:19AM	Telehealth Stock Looks Primed for a Short Squeeze (Schaeffer's Research)
08:05AM	The Weight-Loss Craze Boosted The $186 Billion Telehealth Industry. What It Means For Investors. (Investor's Business Daily)
Sep-18-25 11:51AM	Hims & Hers, Eli Lilly, Novo Nordisk Face FDA Scrutiny: What It Means For Weight-Loss ETFs (Benzinga) +11.62%
Sep-17-25 02:03PM	Weight-loss drug giants face sternest test yet (TheStreet)
Sep-16-25 04:14PM	FDA Slams Hims & Hers With A Warning Letter. Investors Slam Hims Stock. (Investor's Business Daily) -5.69%
04:11PM	Stocks to Watch Recap: Hershey, Oracle, New York Times (The Wall Street Journal)
02:51PM	Hims & Hers Health (HIMS) Stock Trades Down, Here Is Why (StockStory)
02:11PM	Gold's record high, Rocket Lab equity offering, FDA warns Hims (Yahoo Finance Video)
02:01PM	Leverage Shares Launches First 3x Single-Stock ETPs on HOOD, HIMS, UNH and Others (etf.com)
12:59PM	Hims & Hers Health, Inc. (HIMS): A Bull Case Theory (Insider Monkey)
11:28AM	Huge News for Hims & Hers Stock (Motley Fool)
10:23AM	Hims & Hers Expands AI and Technology Focus to Advance Digital Care (Zacks)
09:23AM	Company News for Sep 16, 2025 (Zacks)
12:03AM	Hims & Hers Health (HIMS): Buy, Sell, or Hold Post Q2 Earnings? (StockStory)
Sep-15-25 05:45PM	Hims & Hers Health, Inc. (HIMS) Stock Sinks As Market Gains: Here's Why (Zacks)
12:26PM	Hims & Hers Is in the FDA's Crosshairs. It's a Risk to the Stock. (Barrons.com)
11:41AM	Hims & Hers Stock Falls After FDA Warns on Super Bowl Campaign (GuruFocus.com)
11:40AM	OMCL or HIMS: Which Is the Better Value Stock Right Now? (Zacks)
09:34AM	Musk buys Tesla, China vs. US chips, Hims: Trending Tickers (Yahoo Finance Video)
09:00AM	Investors Heavily Search Hims & Hers Health, Inc. (HIMS): Here is What You Need to Know (Zacks)
07:25AM	Hims & Hers shares drop after FDA chief flags ad violations (Investing.com)
Sep-12-25 04:01PM	Hims & Hers Health (HIMS) Stock Trades Up, Here Is Why (StockStory) +7.23%
10:02AM	Hims & Hers Surges 64.1% in 6 Months: How to Play the Stock? (Zacks)
Sep-11-25 11:56AM	Hims & Hers Health (HIMS) Stock Trades Up, Here Is Why (StockStory) +8.33%
Sep-10-25 01:30PM	Why Hims & Hers Health (HIMS) Stock Is Trading Up Today (StockStory)
11:25AM	Hims & Hers Stock Jumps On Long-Awaited Foray Into Testosterone (Investor's Business Daily)
11:05AM	Trump tasks FDA to crack down on misleading drug advertising (Pharmaceutical Technology)
09:00AM	Hims Launches New Category in Men's Health with Exclusive Branded Oral Testosterone and Expanded Personalized Treatments (Business Wire)
08:50AM	Hims & Hers Health Expands Testosterone Offerings (The Wall Street Journal)
Sep-09-25 07:12PM	Trump aims to curb direct-to-consumer ads for drugs. Hims & Hers Health could be targeted. (MarketWatch)
05:45PM	Hims & Hers Health, Inc. (HIMS) Stock Drops Despite Market Gains: Important Facts to Note (Zacks)
Sep-08-25 11:10AM	Hims & Hers Expanding Partnerships to Build a Global Health Ecosystem (Zacks)
Sep-04-25 02:33PM	Hims & Hers 'Personalized' Health Products Drove A 1,600% Share Price Increase In Less Than 4 Years (Investor's Business Daily) +8.21%
12:33PM	Hims & Hers (HIMS) Steals Spotlight as Court Junks Eli Lilly Lawsuit vs 4 Telehealth Firms (Insider Monkey)
12:16PM	Why Hims & Hers Health (HIMS) Stock Is Up Today (StockStory)
06:24AM	4 Top Stocks to Buy in September (Motley Fool)
Sep-03-25 02:12PM	Lyft convertible notes, Hims & Hers surges, Constellation Brands (Yahoo Finance Video) +7.06%
01:19PM	Hims & Hers gains after court rejects Eli Lillys case against Willow (Investing.com)
Sep-02-25 04:25PM	Here is What to Know Beyond Why Hims & Hers Health, Inc. (HIMS) is a Trending Stock (Zacks)
01:11PM	HIMS' Personalized Wellness Platform Expands Preventive Care Access (Zacks)
Aug-28-25 10:08AM	HIMS vs. AMWL: Which Stock Has the Stronger Global Growth Strategy? (Zacks)
Aug-27-25 03:00PM	Why Cracker Barrel is on its way to meme stock status (Yahoo Finance Video)
10:44AM	Hims & Hers Scales Growth Through Subscriptions and Care Expansion (Zacks)
Aug-25-25 10:30AM	BC-Most Active Stocks (Associated Press Finance)
Aug-22-25 09:00AM	Is Trending Stock Hims & Hers Health, Inc. (HIMS) a Buy Now? (Zacks)
Aug-21-25 11:31PM	Healthcare Technology Stocks Q2 Highlights: Hims & Hers Health (NYSE:HIMS) (StockStory)
02:53PM	Got $5,000? 3 Tech Stocks to Buy and Hold for the Long Term (Motley Fool)
09:05AM	Ozempic Boom: Hims & Eli Lilly Lead Healthcare Bets (MarketBeat)
Aug-20-25 12:33AM	Truist Cuts Hims & Hers Health, Inc. (HIMS) Price Target, Cites Mixed Revenue Outlook (Insider Monkey)
Aug-19-25 04:50PM	Why Hims & Hers Health (HIMS) Stock Is Falling Today (StockStory) -6.47%
04:43PM	Shareholders of Hims & Hers Health, Inc. (HIMS): Protect Your Rights Before August 25, 2025 - Contact Levi & Korsinsky (Newsfile)
10:01AM	Hims & Hers Fuels Growth via Market Expansion and New Care Verticals (Zacks)
Aug-18-25 07:04PM	Insiders Trade Millions in NVIDIA-Linked Navitas, Hims, & Shift4 (MarketBeat)
01:00PM	Why is GDRX stock up 30% today? GoodRx strikes deal to sell Ozempic and Wegovy after Novo Nordisks breakup with Hims (FastCompany)
12:34PM	Wegovy News Pushes Novo Nordisk Stock Higher (Barrons.com)
12:18PM	Meta's reported shake-up, Hims & Hers sinks on GoodRxNovo deal (Yahoo Finance Video)
10:30AM	BC-Most Active Stocks (Associated Press Finance)
09:00AM	GoodRx stock soars after striking deal to sell Novo Nordisk's GLP-1s for $499/month (Yahoo Finance)
09:00AM	GoodRx begins selling Novo Nordisk GLP-1s for cash price (Yahoo Finance)
09:00AM	Novo Nordisk Stock Is Jumping. The Good News Pushing Shares Higher. (Barrons.com)
07:27AM	Stock Market Today: All's quiet on the Wyoming front (TheStreet)

Hims & Hers Health, Inc. operates a telehealth consultation platform. It connects consumers to healthcare professionals, enabling them to access medical care for mental health, sexual health, dermatology and primary care. The company was founded in 2017 and is headquartered in San Francisco, CA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Chi Michael	Chief Commercial Officer	Oct 10 '25	Option Exercise	6.82	900	6,138	292,339	Oct 14 04:17 PM
Chi Michael	Chief Commercial Officer	Oct 10 '25	Sale	58.25	900	52,425	291,439	Oct 14 04:17 PM
Boughton Soleil	Chief Legal Officer	Oct 13 '25	Sale	54.38	2,637	143,400	161,130	Oct 14 04:17 PM
Boughton Soleil	Officer	Oct 13 '25	Proposed Sale	54.38	2,637	143,400		Oct 14 06:47 AM
Chi Michael	Officer	Oct 10 '25	Proposed Sale	58.25	900	52,425		Oct 10 11:26 AM
Okupe Oluyemi	Chief Financial Officer	Oct 03 '25	Option Exercise	7.15	11,595	82,919	81,827	Oct 07 04:47 PM
Okupe Oluyemi	Chief Financial Officer	Oct 03 '25	Sale	57.72	11,595	669,232	70,232	Oct 07 04:47 PM
Chi Michael	Chief Commercial Officer	Oct 01 '25	Option Exercise	11.53	250	2,882	291,689	Oct 02 04:10 PM
Chi Michael	Chief Commercial Officer	Oct 01 '25	Sale	56.00	250	14,000	291,439	Oct 02 04:10 PM
Chi Michael	Officer	Oct 01 '25	Proposed Sale	56.00	250	14,000		Oct 01 11:34 AM
Okupe Oluyemi	Chief Financial Officer	Sep 29 '25	Option Exercise	5.01	49,832	249,658	155,232	Sep 30 04:33 PM
Okupe Oluyemi	Chief Financial Officer	Sep 29 '25	Sale	60.20	85,000	5,116,924	70,232	Sep 30 04:33 PM
Boughton Soleil	Chief Legal Officer	Sep 29 '25	Sale	58.79	2,637	155,029	163,767	Sep 30 04:33 PM
Boughton Soleil	Officer	Sep 29 '25	Proposed Sale	58.79	2,637	155,029		Sep 29 09:51 AM
Chi Michael	Chief Commercial Officer	Sep 24 '25	Option Exercise	5.01	2,100	10,521	293,539	Sep 25 06:06 PM
Chi Michael	Chief Commercial Officer	Sep 24 '25	Sale	56.52	2,100	118,692	291,439	Sep 25 06:06 PM
Okupe Oluyemi	Chief Financial Officer	Sep 22 '25	Sale	57.74	23,584	1,361,766	105,400	Sep 24 04:22 PM
Chi Michael	Officer	Sep 24 '25	Proposed Sale	56.52	2,100	118,692		Sep 24 11:02 AM
Oluyemi Okupe	Officer	Sep 22 '25	Proposed Sale	57.70	154,958	8,941,077		Sep 22 05:39 PM
Boughton Soleil	Chief Legal Officer	Sep 17 '25	Sale	50.50	2,637	133,168	166,404	Sep 19 04:28 PM
Carroll Patrick Harrison	Chief Medical Officer	Sep 17 '25	Sale	50.50	10,021	506,060	169,940	Sep 19 04:28 PM
Becklund Irene	PAO	Sep 17 '25	Sale	50.50	8,410	424,705	1,418	Sep 19 04:28 PM
Chi Michael	Chief Commercial Officer	Sep 17 '25	Sale	50.50	13,749	694,324	297,139	Sep 19 04:27 PM
Dudum Andrew	Chief Executive Officer	Sep 17 '25	Sale	50.57	65,110	3,292,906	95,315	Sep 19 04:27 PM
Chi Michael	Chief Commercial Officer	Sep 15 '25	Option Exercise	6.19	4,150	25,680	282,804	Sep 17 07:24 PM
Chi Michael	Chief Commercial Officer	Sep 15 '25	Sale	56.00	4,150	232,400	278,654	Sep 17 07:24 PM
Dudum Andrew	Chief Executive Officer	Sep 16 '25	Option Exercise	2.43	125,335	304,564	268,759	Sep 17 07:24 PM
Dudum Andrew	Chief Executive Officer	Sep 16 '25	Sale	53.48	128,127	6,852,300	160,425	Sep 17 07:24 PM
Dudum Andrew	Chief Executive Officer	Sep 16 '25	Sale	53.27	47,534	2,532,325	95,058	Sep 17 07:24 PM
Okupe Oluyemi	Chief Financial Officer	Sep 15 '25	Option Exercise	5.01	110,000	551,100	273,984	Sep 17 07:24 PM
Okupe Oluyemi	Chief Financial Officer	Sep 15 '25	Sale	55.35	145,000	8,026,076	128,984	Sep 17 07:24 PM
Dudum Andrew	Officer	Sep 17 '25	Proposed Sale	50.57	65,110	3,292,904		Sep 17 12:44 PM
Boughton Soleil	Officer	Sep 17 '25	Proposed Sale	50.50	2,637	133,168		Sep 17 11:15 AM
Carroll Patrick Harrison	Officer	Sep 17 '25	Proposed Sale	50.50	10,021	506,060		Sep 17 10:20 AM
Chi Michael	Officer	Sep 17 '25	Proposed Sale	50.50	13,749	694,324		Sep 17 10:07 AM
Becklund Irene	Officer	Sep 17 '25	Proposed Sale	50.50	8,410	424,705		Sep 17 09:50 AM
Dudum Andrew	Officer	Sep 16 '25	Proposed Sale	53.42	175,661	9,384,626		Sep 16 11:29 AM
Oluyemi Okupe	Officer	Sep 15 '25	Proposed Sale	53.96	145,000	7,824,200		Sep 15 06:35 PM
Chi Michael	Officer	Sep 15 '25	Proposed Sale	56.00	4,150	232,400		Sep 15 11:49 AM
Okupe Oluyemi	Chief Financial Officer	Aug 26 '25	Option Exercise	5.01	11,581	58,021	128,387	Aug 28 04:34 PM
Okupe Oluyemi	Chief Financial Officer	Aug 26 '25	Sale	43.69	11,581	505,968	116,806	Aug 28 04:34 PM
Boughton Soleil	Chief Legal Officer	Aug 25 '25	Sale	44.53	2,571	114,487	150,450	Aug 26 04:35 PM
Boughton Soleil	Officer	Aug 25 '25	Proposed Sale	44.53	2,571	114,487		Aug 25 09:46 AM
Dudum Andrew	Chief Executive Officer	Aug 18 '25	Option Exercise	2.43	125,335	304,564	197,855	Aug 20 04:14 PM
Dudum Andrew	Chief Executive Officer	Aug 18 '25	Sale	45.06	128,127	5,773,242	89,521	Aug 20 04:14 PM
Dudum Andrew	Chief Executive Officer	Aug 18 '25	Sale	45.05	47,534	2,141,492	142,592	Aug 20 04:14 PM
Dudum Andrew	Officer	Aug 18 '25	Proposed Sale	45.05	47,534	2,141,494		Aug 18 12:33 PM
Dudum Andrew	Officer	Aug 18 '25	Proposed Sale	45.22	128,127	5,793,903		Aug 18 10:22 AM
Okupe Oluyemi	Chief Financial Officer	Aug 13 '25	Option Exercise	5.01	11,581	58,021	65,665	Aug 15 04:18 PM
Okupe Oluyemi	Chief Financial Officer	Aug 13 '25	Sale	48.05	11,581	556,420	116,806	Aug 15 04:18 PM
Melissa Baird	Officer	Aug 12 '25	Proposed Sale	47.96	33,333	1,598,651		Aug 12 05:22 PM
Boughton Soleil	Chief Legal Officer	Aug 11 '25	Sale	51.64	2,572	132,818	153,021	Aug 12 04:33 PM
Dudum Andrew	Chief Executive Officer	Aug 07 '25	Sale	50.58	660,000	33,384,120	2,214,769	Aug 11 05:07 PM
Boughton Soleil	Officer	Aug 11 '25	Proposed Sale	51.64	2,572	132,818		Aug 11 10:18 AM
Carroll Patrick Harrison	Chief Medical Officer	Aug 06 '25	Sale	53.58	60,000	3,214,878	169,940	Aug 08 04:19 PM
Carroll Patrick Harrison	Officer	Aug 06 '25	Proposed Sale	53.58	60,000	3,214,881		Aug 06 01:27 PM
Chi Michael	Chief Commercial Officer	Jul 31 '25	Option Exercise	7.09	26,350	186,830	305,004	Aug 04 04:21 PM
Chi Michael	Chief Commercial Officer	Aug 01 '25	Option Exercise	11.53	250	2,882	278,904	Aug 04 04:21 PM
Chi Michael	Chief Commercial Officer	Jul 31 '25	Sale	67.00	26,350	1,765,450	278,654	Aug 04 04:21 PM
Chi Michael	Chief Commercial Officer	Aug 01 '25	Sale	64.44	250	16,110	278,654	Aug 04 04:21 PM
Chi Michael	Officer	Aug 01 '25	Proposed Sale	64.44	250	16,110		Aug 01 11:12 AM
Chi Michael	Officer	Jul 31 '25	Proposed Sale	67.00	26,350	1,765,450		Jul 31 11:02 AM
Boughton Soleil	Chief Legal Officer	Jul 28 '25	Sale	58.70	2,572	150,976	155,593	Jul 29 04:25 PM
Boughton Soleil	Officer	Jul 28 '25	Proposed Sale	58.70	2,572	150,976		Jul 28 12:59 PM
Chi Michael	Chief Commercial Officer	Jul 23 '25	Option Exercise	5.25	13,750	72,146	292,404	Jul 25 05:20 PM
Chi Michael	Chief Commercial Officer	Jul 24 '25	Option Exercise	5.01	2,100	10,521	280,754	Jul 25 05:20 PM
Chi Michael	Chief Commercial Officer	Jul 23 '25	Sale	56.00	13,750	770,000	278,654	Jul 25 05:20 PM
Chi Michael	Chief Commercial Officer	Jul 24 '25	Sale	57.52	2,100	120,792	278,654	Jul 25 05:20 PM
Chi Michael	Officer	Jul 24 '25	Proposed Sale	57.52	2,100	120,792		Jul 24 10:44 AM
Dudum Andrew	Chief Executive Officer	Jul 21 '25	Option Exercise	2.43	125,335	304,564	142,313	Jul 23 04:12 PM
Dudum Andrew	Chief Executive Officer	Jul 21 '25	Sale	49.54	125,335	6,208,637	92,313	Jul 23 04:12 PM
Chi Michael	Officer	Jul 23 '25	Proposed Sale	56.00	13,750	770,000		Jul 23 12:19 PM
Melissa Baird	Officer	Jul 21 '25	Proposed Sale	47.60	33,333	1,586,651		Jul 21 04:59 PM
Dudum Andrew	Officer	Jul 21 '25	Proposed Sale	49.54	125,335	6,208,636		Jul 21 10:41 AM
Dudum Andrew	Chief Executive Officer	Jul 16 '25	Sale	50.25	47,534	2,388,817	190,126	Jul 18 04:29 PM
Dudum Andrew	Chief Executive Officer	Jul 16 '25	Sale	50.58	2,792	141,217	92,313	Jul 18 04:29 PM
Dudum Andrew	Officer	Jul 16 '25	Proposed Sale	50.27	50,326	2,530,033		Jul 16 11:49 AM
Boughton Soleil	Chief Legal Officer	Jul 14 '25	Sale	47.82	2,572	122,993	158,165	Jul 15 04:28 PM
Okupe Oluyemi	Chief Financial Officer	Jul 14 '25	Option Exercise	5.01	7,587	38,011	65,665	Jul 15 04:28 PM
Okupe Oluyemi	Chief Financial Officer	Jul 14 '25	Sale	47.70	11,581	552,418	54,084	Jul 15 04:28 PM
Boughton Soleil	Officer	Jul 14 '25	Proposed Sale	47.82	2,572	122,993		Jul 14 12:25 PM
Melissa Baird	Officer	Jul 08 '25	Proposed Sale	48.96	33,333	1,631,984		Jul 08 04:48 PM
Okupe Oluyemi	Chief Financial Officer	Jul 07 '25	Option Exercise	5.01	6,437	32,249	69,659	Jul 08 04:40 PM
Okupe Oluyemi	Chief Financial Officer	Jul 07 '25	Sale	46.67	11,581	540,498	58,078	Jul 08 04:40 PM
Boughton Soleil	Chief Legal Officer	Jun 30 '25	Sale	50.50	2,572	129,886	160,737	Jul 01 04:45 PM
Boughton Soleil	Officer	Jun 30 '25	Proposed Sale	50.50	2,572	129,886		Jun 30 10:56 AM
Okupe Oluyemi	Chief Financial Officer	Jun 23 '25	Sale	47.25	23,107	1,091,766	63,222	Jun 24 04:31 PM
Oluyemi Okupe	Officer	Jun 23 '25	Proposed Sale	41.98	69,431	2,914,713		Jun 23 04:49 PM
Chi Michael	Chief Commercial Officer	Jun 17 '25	Sale	59.75	17,102	1,021,844	278,654	Jun 17 08:07 PM
Dudum Andrew	Chief Executive Officer	Jun 16 '25	Option Exercise	2.43	125,335	304,564	285,550	Jun 17 08:07 PM
Dudum Andrew	Chief Executive Officer	Jun 16 '25	Sale	56.76	128,127	7,271,950	160,215	Jun 17 08:07 PM
Dudum Andrew	Chief Executive Officer	Jun 17 '25	Sale	59.22	65,110	3,855,542	95,105	Jun 17 08:07 PM
Dudum Andrew	Chief Executive Officer	Jun 16 '25	Sale	56.51	47,534	2,686,300	237,660	Jun 17 08:07 PM
Boughton Soleil	Chief Legal Officer	Jun 16 '25	Sale	56.80	5,451	309,617	165,881	Jun 17 08:06 PM
Boughton Soleil	Chief Legal Officer	Jun 17 '25	Sale	59.75	2,572	153,677	163,309	Jun 17 08:06 PM
Becklund Irene	PAO	Jun 17 '25	Sale	59.75	8,485	506,979	712	Jun 17 08:06 PM
Chi Michael	Officer	Jun 17 '25	Proposed Sale	59.75	17,102	1,021,844		Jun 17 12:42 PM
Dudum Andrew	Officer	Jun 17 '25	Proposed Sale	59.22	65,110	3,855,544		Jun 17 12:13 PM
Becklund Irene	Officer	Jun 17 '25	Proposed Sale	59.75	8,485	506,979		Jun 17 11:19 AM
Boughton Soleil	Officer	Jun 17 '25	Proposed Sale	59.75	2,572	153,677		Jun 17 10:20 AM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

HIMS

Hims & Hers Health Inc

Upgrade your FINVIZ experience